Crossmark

Prostatic artery embolization must be considered as a valid treatment option of benign prostatic hyperplasia particularly in patients having serious comorbidities

Crossref DOI link: https://doi.org/10.1007/s00345-023-04315-0

Published Online: 2023-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tonyali, Senol https://orcid.org/0000-0003-1657-4044
Miernik, Arkadiusz
License Information

Text and Data Mining valid from 2023-02-11

Version of Record valid from 2023-02-11
More Information

Article History

Received: 23 January 2023

Accepted: 23 January 2023

First Online: 11 February 2023

Declarations

:

: The author declares that they have no conflict of interest. Senol Tonyali has received a grant from European Association of Urology Scholarship Programme.

: This article does not contain any studies with human participants performed by the authors.

Document is current

Any future updates will be listed below